D-0161-2027 Class II Ongoing

Recalled by BioMed Laboratories, LLC. — Dallas, TX

FDA drug recall D-0161-2027 was initiated by BioMed Laboratories, LLC. on Oct 15, 2026 and is designated Class II. Reason for recall: Failed Stability Specifications: OOS stability results included viscosity and appearance results that did not align with the established specifications. The recall status is ongoing. Affected quantity: 11,130 bottles.

Recall details

Product Type
Drugs
Report Date
Nov 11, 2026
Initiation Date
Oct 15, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
11,130 bottles

Product description

Tychasis Coats Aloe Liniment (Methyl salicylate 10%), packaged a) 0.5 oz, b) 8 oz (NDC 70211-704-08) c) 33oz (NDC 70211-704-33) bottles, Manufactured for: Tychasis Corporation, Dallas, TX 75227. There is no NDC for the 0.5 oz given that it is a sample size used as a professional sample.

Reason for recall

Failed Stability Specifications: OOS stability results included viscosity and appearance results that did not align with the established specifications.

Distribution pattern

TX only

Code information

Lot #: a)0.5 oz 0001882607, Exp. Date Jul-31-2027; b) 0001882605, 0001916439 Exp. Date Jul-31-2027; c) Lot #: 0001882606, Exp. Date Jul-31-2027

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0161-2027
openFDA file date
Nov 19, 2026
Loaded by RegDataLab
Nov 20, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Need the full FDA record for BioMed Laboratories, LLC.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: openFDA record for D-0161-2027. Report a data issue: hello@regdatalab.com.